Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 270-735-1 | CAS number: 68477-50-9 A complex combination of hydrocarbons obtained from the distillation of polymerized steam-cracked petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C12.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP compliant, guideline study, available as unpublished report, minor restrictions in design and/or reporting but otherwise adequate for assessment.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 992
- Report date:
- 1992
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Details on test material:
- - Name of test material (as cited in study report): MRD-91-935
- Physical state: pale yellow liquid
- Analytical purity: considered 100%
- Lot/batch No.: 1
- Expiration date of the lot/batch: 31 May 1996
- Storage condition of test material: room temperature
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- B6C3F1
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Portage, Shaver Road, Portage, Michigan 49081, USA
- Age at study initiation: Approximately 8 to 9 weeks
- Weight at study initiation: 20 - 29 g three days prior to experimental start
- Assigned to test groups randomly: yes, using a computer generated, body weight sorting program
- Housing: Individually in suspended stainless steel cages
- Diet: Purina Certified Rodent 5002 Chow (pellets) ad libitum (except during exposure) Ralston Purina Company, Checkerboard Square, St. Louis, Missouri, 63164, USA
- Water: Mains water ad libitum
- Acclimatisation period: 20 days
ENVIRONMENTAL CONDITIONS
- Temperature: 68-76°F
- Humidity: 29-71%
- Air changes (per hr): Not reported
- Photoperiod: 12hrs dark / 12hrs light
IN-LIFE DATES: From: 5 August 1991 To: 12 September 1991
Administration / exposure
- Route of administration:
- inhalation
- Vehicle:
- - Vehicle(s)/solvent(s) used: air
- Details on exposure:
- TYPE OF INHALATION EXPOSURE: whole body
GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
The test material was delivered to the inside of a cylindrical glass vapour generator. The test material evaporated as it flowed down the heated generator. Resultant vapours were mixed with room air as both were drawn up through the generator and into the exposure chamber. The exposure chambers (volume approximately 1000 L) operated under slight negative pressure at 200 L/min airflow. The theoretical equilibration time (T99) was 23 mins.
TEST ATMOSPHERE
- Brief description of analytical method used: Gas chromatography
- Samples taken from breathing zone: yes - Duration of treatment / exposure:
- 2 days
- Frequency of treatment:
- 6 hours/day for 2 consecutive days
- Post exposure period:
- Approximately 24, 48 or 72 hours after second exposure (test and negative control groups). Approximately 25.5 hours after single ip injection for cyclophosphamide (positive control).
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
0, 30, 100, 300 ppm
Basis:
other: target exposure concentrations
- Remarks:
- Doses / Concentrations:
0, 30, 102, 309 ppm
Basis:
analytical conc.
- Remarks:
- Doses / Concentrations:
N/A, 37, 117, 337 ppm
Basis:
nominal conc.
- No. of animals per sex per dose:
- 15/sex (i.e. 5/sex/sacrifice interval) for test and negative controls. 5/sex for positive control
- Control animals:
- yes, sham-exposed
- Positive control(s):
- cyclophosphamide
- Route of administration: single intraperitoneal injection
- Doses / concentrations: 40 mg/kg bodyweight (carrier water)
Examinations
- Tissues and cell types examined:
- polychromatic erythrocytes of the bone marrow of B6C3F1 mice
- Details of tissue and slide preparation:
- TREATMENT AND SAMPLING TIMES: Five animals/sex were killed approximately 24, 48 and 72 hours after second exposure period (MRD-91-935 and negative (air) controls). Positive controls were killed approximately 25.5 hours following dosing. Immediately after death, both femurs were removed. The bone marrow was then removed and suspended in foetal bovine serum. After the suspension was centrifuged, the pellet was resuspended and smears were prepared (two slides per animal).
DETAILS OF SLIDE PREPARATION: Slides were stained using acridine orange - Evaluation criteria:
- Polychromatic erythrocytes (PCE), normochromatic erythrocytes (NCE) and micronuclei identified by stain. Additional criteria for scoring micronuclei are a circular appearance and a diameter between 1/20 and 1/5 of the cell's diameter. 1000 polychromatic erythrocytes (PCE) from each animal were examined for micronuclei, and the ratio of PCE's to NCE's was determined for each animal by counting 1000 erythrocytes (PCE's and NCE's).
- Statistics:
- Statistical analysis included calculation of means and standard deviations of the micronuclei data and a test of equality of group means by a standard one way analysis of variance at each time period. When the ANOVA was significant, comparisons of control to dosed group means were by Duncan's Multiple Range Test. A standard regression analysis was performed to test for a dose response. Residuals from the ANOVA were analyzed for normality by Wilk's Criterion. The residuals were normally distributed (at the 0.01 level of significance) in more than 25% of the analyses. Therefore nonparametric analyses were not performed.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
- Dose range: 100, 500, 2000 ppm
- Clinical signs of toxicity in test animals: All animals at 500 and 2000 ppm died prior to second day of dosing. All animals exposed at 100 ppm survived.
Based on the range finding study results, the doses used for the mutation assay were 30, 100 and 300 ppm of test material in air.
RESULTS OF DEFINITIVE STUDY
- Induction of micronuclei: MRD-91-935 did not induce a statistically significant increase in the mean number of micronucleated polychromatic erythrocytes.
- Ratio of PCE/NCE: MRD-91-935 did not induce a statistically significant decrease in the mean percent of polychromatic erythrocytes which is a measure of bone marrow toxicity.
- Positive control: Induced a statistically significant increase in the mean number of micronucleated polychromatic erythrocytes which indicates that the positive control is clastogenic and is responding in an appropriate manner.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
MRD-91-935 was not toxic to mouse bone marrow under the conditions of this test. MRD-91-935 was not clastogenic in bone marrow of B6C3F1 mice. - Executive summary:
MRD-91-935 did not induce a statistically significant decrease in the mean percent of polychromatic erythrocytes which is a measure of bone marrow toxicity. Thus MRD-91-935 was not toxic to mouse bone marrow under the conditions of this test. This test material did not induce a statistically significant increase in the mean number of micronucleated polychromatic erythrocytes. Thus MRD-91-935 was not clastogenic in bone marrow of B6C3F1 mice.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)
Although ECHA is providing a lot of online material in your language, part of this page is only in English. More about ECHA’s multilingual practice.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
the-echa-website-uses-cookies
find-out-more-on how-we-use-cookies